Sagent Pharmaceuticals and Itochu Chemical Frontier Corporation Announce Development and Manufacturing Collaboration
News Oct 22, 2008
Sagent Pharmaceuticals, Inc. and Itochu Chemical Frontier Corporation (ICF) have announced finalization of a development and supply collaboration. Under the agreement, ICF will supply injectable products for which Sagent will obtain U.S. regulatory approval and market in the United States.
"We are extremely pleased to partner with a global company of Itochu's caliber and skills on these exciting product opportunities," said Jeffrey M. Yordon, CEO, founder and chairman of the board of Sagent Pharmaceuticals, Inc.
"Sagent is committed to expanding its network of worldwide strategic partnerships to offer the most diverse and extensive pipeline of the highest quality injectable products to our hospital focused customers and we look forward to including ICF amongst our partners."
"ICF looks forward to rapidly expanding our presence in the U.S. market," said Jun Sato, ICF's president and chief executive officer. "We believe that this collaboration combining ICF's experience in the Japanese market with Sagent's U.S. focused injectable selling and marketing capabilities is an optimal path toward achieving this objective."
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Molecule Prevents Common Cold Virus from Hijacking Human CellsNews
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.READ MORE
Improving Pharmaceuticals: Catalyst Specifically Tuned to Integrate Fluorine AtomsNews
In the race to create more potent and stable medicines, scientists know that adding fluorine can improve drug molecules. However, there is only one fluorination reaction known to occur in nature which is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely.READ MORE
Comments | 0 ADD COMMENT
World Congress on Bio-organic and Medicinal Chemistry
Nov 12 - Nov 13, 2018